BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 10411262)

  • 1. Mechanisms of pyrazinamide resistance in mycobacteria: importance of lack of uptake in addition to lack of pyrazinamidase activity.
    Raynaud C; Lanéelle MA; Senaratne RH; Draper P; Lanéelle G; Daffé M
    Microbiology (Reading); 1999 Jun; 145 ( Pt 6)():1359-1367. PubMed ID: 10411262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced pyrazinamidase activity and the natural resistance of Mycobacterium kansasii to the antituberculosis drug pyrazinamide.
    Sun Z; Zhang Y
    Antimicrob Agents Chemother; 1999 Mar; 43(3):537-42. PubMed ID: 10049264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pncA gene from naturally pyrazinamide-resistant Mycobacterium avium encodes pyrazinamidase and confers pyrazinamide susceptibility to resistant M. tuberculosis complex organisms.
    Sun Z; Scorpio A; Zhang Y
    Microbiology (Reading); 1997 Oct; 143 ( Pt 10)():3367-3373. PubMed ID: 9353938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of pyrazinamidase activity using a cell-free
    Rueda D; Bernard C; Gandy L; Capton E; Boudjelloul R; Brossier F; Veziris N; Zimic M; Sougakoff W
    Int J Mycobacteriol; 2018; 7(1):16-25. PubMed ID: 29516881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metallochaperones Are Needed for Mycobacterium tuberculosis and Escherichia coli Nicotinamidase-Pyrazinamidase Activity.
    Sheen P; Monsalve A; Campos J; Huerta R; Antiparra R; Arteaga H; Duran P; Bueno C; Kirwan DE; Gilman RH; Zimic M
    J Bacteriol; 2020 Jan; 202(2):. PubMed ID: 31636108
    [No Abstract]   [Full Text] [Related]  

  • 6. pncA gene expression and prediction factors on pyrazinamide resistance in Mycobacterium tuberculosis.
    Sheen P; Lozano K; Gilman RH; Valencia HJ; Loli S; Fuentes P; Grandjean L; Zimic M
    Tuberculosis (Edinb); 2013 Sep; 93(5):515-22. PubMed ID: 23867321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of acid pH and deficient efflux of pyrazinoic acid in unique susceptibility of Mycobacterium tuberculosis to pyrazinamide.
    Zhang Y; Scorpio A; Nikaido H; Sun Z
    J Bacteriol; 1999 Apr; 181(7):2044-9. PubMed ID: 10094680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The paradox of pyrazinamide: an update on the molecular mechanisms of pyrazinamide resistance in Mycobacteria.
    Singh P; Mishra AK; Malonia SK; Chauhan DS; Sharma VD; Venkatesan K; Katoch VM
    J Commun Dis; 2006 Mar; 38(3):288-98. PubMed ID: 17373362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada.
    Cheng SJ; Thibert L; Sanchez T; Heifets L; Zhang Y
    Antimicrob Agents Chemother; 2000 Mar; 44(3):528-32. PubMed ID: 10681313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Mycobacterium smegmatis pyrazinamidase in Mycobacterium tuberculosis confers hypersensitivity to pyrazinamide and related amides.
    Boshoff HI; Mizrahi V
    J Bacteriol; 2000 Oct; 182(19):5479-85. PubMed ID: 10986252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revelation of enzyme activity of mutant pyrazinamidases from Mycobacterium tuberculosis upon binding with various metals using quantum mechanical approach.
    Rasool N; Husssain W; Khan YD
    Comput Biol Chem; 2019 Dec; 83():107108. PubMed ID: 31442707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis.
    Scorpio A; Lindholm-Levy P; Heifets L; Gilman R; Siddiqi S; Cynamon M; Zhang Y
    Antimicrob Agents Chemother; 1997 Mar; 41(3):540-3. PubMed ID: 9055989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus.
    Scorpio A; Zhang Y
    Nat Med; 1996 Jun; 2(6):662-7. PubMed ID: 8640557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and phenotypic characterization of pyrazinamide-resistant mycobacterium tuberculosis complex isolates in Japan.
    Miyagi C; Yamane N; Yogesh B; Ano H; Takashima T
    Diagn Microbiol Infect Dis; 2004 Feb; 48(2):111-6. PubMed ID: 14972380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esters of Pyrazinoic Acid Are Active against Pyrazinamide-Resistant Strains of Mycobacterium tuberculosis and Other Naturally Resistant Mycobacteria In Vitro and Ex Vivo within Macrophages.
    Pires D; Valente E; Simões MF; Carmo N; Testa B; Constantino L; Anes E
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7693-9. PubMed ID: 26438493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical Characterization and Computational Identification of Mycobacterium tuberculosis Pyrazinamidase in Some Pyrazinamide-Resistant Isolates of Iran.
    Doustdar F; Pazhang M; Mehrnejad F; Safarzadeh M; Rabiei D; Chaparzadeh N; Falahati H; Mir-Derikvand M
    Protein J; 2015 Jun; 34(3):181-92. PubMed ID: 25972249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrazinoic acid efflux rate in Mycobacterium tuberculosis is a better proxy of pyrazinamide resistance.
    Zimic M; Fuentes P; Gilman RH; Gutiérrez AH; Kirwan D; Sheen P
    Tuberculosis (Edinb); 2012 Jan; 92(1):84-91. PubMed ID: 22004792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Novel Efflux Proteins Rv0191, Rv3756c, Rv3008, and Rv1667c Involved in Pyrazinamide Resistance in Mycobacterium tuberculosis.
    Zhang Y; Zhang J; Cui P; Zhang Y; Zhang W
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis.
    Hirano K; Takahashi M; Kazumi Y; Fukasawa Y; Abe C
    Tuber Lung Dis; 1997; 78(2):117-22. PubMed ID: 9692180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of pncA sequence with pyrazinamide resistance level in BACTEC for 21 mycobacterium tuberculosis clinical isolates.
    Mestdagh M; Realini L; Fonteyne PA; Rossau R; Jannes G; Mijs W; DE Smet KA; Portaels F; Van den Eeckhout E
    Microb Drug Resist; 2000; 6(4):283-7. PubMed ID: 11272256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.